P111 - Segurança CV da Dapagliflozina - estudo DECLARE - Carlos Eduardo Barra Couri - a podcast by SBD

from 2018-12-13T11:33:52

:: ::

Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes. N Engl J Med. 2018 Nov 10.

Further episodes of SBD

Further podcasts by SBD

Website of SBD